JPS5427588A - 11*44aminoo6*77dimethoxyy 22quinazorinyl**44*22 tetrahydrofroyl* piperadine hydrochloride dihydrate - Google Patents

11*44aminoo6*77dimethoxyy 22quinazorinyl**44*22 tetrahydrofroyl* piperadine hydrochloride dihydrate

Info

Publication number
JPS5427588A
JPS5427588A JP8778778A JP8778778A JPS5427588A JP S5427588 A JPS5427588 A JP S5427588A JP 8778778 A JP8778778 A JP 8778778A JP 8778778 A JP8778778 A JP 8778778A JP S5427588 A JPS5427588 A JP S5427588A
Authority
JP
Japan
Prior art keywords
tetrahydrofroyl
44aminoo6
piperadine
hydrochloride dihydrate
dihydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8778778A
Other languages
English (en)
Other versions
JPH0231078B2 (ja
Inventor
Rotsuteman Robaato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26760383&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS5427588(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JPS5427588A publication Critical patent/JPS5427588A/ja
Publication of JPH0231078B2 publication Critical patent/JPH0231078B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP8778778A 1977-08-04 1978-07-20 11*44aminoo6*77dimethoxyy 22quinazorinyl**44*22 tetrahydrofroyl* piperadine hydrochloride dihydrate Granted JPS5427588A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82167577A 1977-08-04 1977-08-04
US06/078,317 US4251532A (en) 1977-08-04 1979-09-24 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate

Publications (2)

Publication Number Publication Date
JPS5427588A true JPS5427588A (en) 1979-03-01
JPH0231078B2 JPH0231078B2 (ja) 1990-07-11

Family

ID=26760383

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8778778A Granted JPS5427588A (en) 1977-08-04 1978-07-20 11*44aminoo6*77dimethoxyy 22quinazorinyl**44*22 tetrahydrofroyl* piperadine hydrochloride dihydrate

Country Status (8)

Country Link
US (1) US4251532A (ja)
JP (1) JPS5427588A (ja)
AU (1) AU517636B2 (ja)
CA (1) CA1081229A (ja)
CH (1) CH635096A5 (ja)
DE (1) DE2831112A1 (ja)
FR (1) FR2399430A1 (ja)
GB (1) GB1591490A (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3579390D1 (de) * 1984-06-22 1990-10-04 Beecham Group Plc Wirksame benzopyranverbindungen.
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
EP0237608B1 (de) * 1986-03-21 1992-01-29 HEUMANN PHARMA GMBH & CO Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung
YU70890A (en) * 1989-04-21 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for obtaining quinazoline derivatives
US5212176A (en) * 1990-06-29 1993-05-18 Abbott Laboratories R(+)-terazosin
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
US5294615A (en) * 1993-04-29 1994-03-15 Abbott Laboratories Terazosin polymorph and pharmaceutical composition
US5412095A (en) * 1993-04-29 1995-05-02 Abbott Laboratories Terazosin monohydrochloride and processes and intermediate for its production
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
US5504207A (en) * 1994-10-18 1996-04-02 Abbott Laboratories Process and intermediate for the preparation of terazosin hydrochloride dihydrate
US5587377A (en) * 1995-10-24 1996-12-24 Invamed, Inc. Terazosin crystalline polymorph and pharmaceutical compositions thereof
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
IT1286790B1 (it) * 1996-11-29 1998-07-17 Alfa Chem Ital Processo per la produzione della forma i del terazosin monocloridrato anidro
IT1286789B1 (it) * 1996-11-29 1998-07-17 Alfa Chem Ital Processo per la produzione della forma i del terazosin monocloridato anidro
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
DK0849266T3 (da) * 1996-12-20 2007-06-04 Heumann Pcs Gmbh Hidtil ukendt polymorf form af doxazosin-mesylat (form III)
US6248888B1 (en) 1997-11-14 2001-06-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of terazosin hydrochloride dihydrate
KR100648869B1 (ko) 1998-09-30 2007-02-28 다케다 야쿠힌 고교 가부시키가이샤 방광 배출력 개선제
CN1649614A (zh) 2002-02-22 2005-08-03 新河药品股份有限公司 活性剂传递系统和保护及施用活性剂的方法
US20070086958A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Formation of medically useful gels comprising microporous particles and methods of use
US20070087061A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
US20070161791A1 (en) * 2006-01-09 2007-07-12 Narsimha Reddy Penthala Process for the preparation of terazosin hydrocloride dihydrate
CN103739596A (zh) * 2013-12-10 2014-04-23 刘磊 用于心脑血管疾病的喹唑啉衍生物
US11224572B1 (en) 2020-08-17 2022-01-18 Novitium Pharma LLC Stable oral liquid composition of terazosin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5248678A (en) * 1975-10-14 1977-04-18 Abbott Lab Hypotensivedrug

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5248678A (en) * 1975-10-14 1977-04-18 Abbott Lab Hypotensivedrug

Also Published As

Publication number Publication date
DE2831112A1 (de) 1979-02-15
US4251532A (en) 1981-02-17
FR2399430B1 (ja) 1982-08-13
GB1591490A (en) 1981-06-24
JPH0231078B2 (ja) 1990-07-11
AU517636B2 (en) 1981-08-13
CH635096A5 (fr) 1983-03-15
AU3781878A (en) 1980-01-10
CA1081229A (en) 1980-07-08
FR2399430A1 (fr) 1979-03-02

Similar Documents

Publication Publication Date Title
JPS5427588A (en) 11*44aminoo6*77dimethoxyy 22quinazorinyl**44*22 tetrahydrofroyl* piperadine hydrochloride dihydrate
GB2003877B (en) Thiazine derivatives
GB2005538B (en) Pharmaceutical compositsions
LU90153I2 (fr) Modiodal 100 mg
DE2861261D1 (en) Hairspray
GB2008101B (en) Pharmaceutical preperations
AU4113878A (en) 1-alkanoyl-proline derivatives
JPS5439085A (en) Therapeutically useful mmtrifluoroomethylphenyll piperadine derivative
JPS5484554A (en) 11nn4*66diioo*aminoglycocyl**1*33diamino sicritol derivatives
JPS53105488A (en) Dibenzodiazepines
MTP837B (en) Derivatives 2 finino-imidazolidire
AU3888578A (en) 4-hydroxy-2-benzimidazolinone derivatives
JPS5346988A (en) Piperadine derivative
JPS53140704A (en) Tireepuncture preventing agent
GB2002771B (en) Thiazine derivatives
NZ186329A (en) N-substituted phenylergolin-8-ylcarboxamides
AU3313978A (en) Everninomicin derivatives
IL56295A0 (en) The preparation of methyliminoisobutyrate hydrochloride
GB2014322B (en) Photocopying
AU4129978A (en) Eburnamenine derivatives
ZA78822B (en) Fungicidal agents
JPS5411239A (en) Dandruff preventing agent
ZA785351B (en) N-substituted benzothiazolines
JPS5390299A (en) 44deoxybincrystine and related compounds thereof
AU4073278A (en) N-substituted mercaptomethylacetamidines